{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T02:38:29Z","timestamp":1786761509652,"version":"build-2736575974"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,8,16]],"date-time":"2016-08-16T00:00:00Z","timestamp":1471305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,8,16]],"date-time":"2016-08-16T00:00:00Z","timestamp":1471305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Previous research implicates altered metabolism of<jats:sc>l<\/jats:sc>-arginine, a versatile amino acid with a number of bioactive metabolites, in the pathogenesis of schizophrenia. The present study, for we believe the first time, systematically compared the metabolic profile of<jats:sc>l<\/jats:sc>-arginine in the frontal cortex (Brodmann\u2019s area 8) obtained post-mortem from schizophrenic individuals and age- and gender-matched non-psychiatric controls (<jats:italic>n<\/jats:italic>=20 per group). The enzyme assays revealed no change in total nitric oxide synthase (NOS) activity, but significantly increased arginase activity in the schizophrenia group. Western blot showed reduced endothelial NOS protein expression and increased arginase II protein level in the disease group. High-performance liquid chromatography and liquid chromatography\/mass spectrometric assays confirmed significantly reduced levels of \u03b3-aminobutyric acid (GABA), but increased agmatine concentration and glutamate\/GABA ratio in the schizophrenia cases. Regression analysis indicated positive correlations between arginase activity and the age of disease onset and between<jats:sc>l<\/jats:sc>-ornithine level and the duration of illness. Moreover, cluster analyses revealed that<jats:sc>l<\/jats:sc>-arginine and its main metabolites<jats:sc>l<\/jats:sc>-citrulline,<jats:sc>l<\/jats:sc>-ornithine and agmatine formed distinct groups, which were altered in the schizophrenia group. The present study provides further evidence of altered brain arginine metabolism in schizophrenia, which enhances our understanding of the pathogenesis of schizophrenia and may lead to the future development of novel preventions and\/or therapeutics for the disease.<\/jats:p>","DOI":"10.1038\/tp.2016.144","type":"journal-article","created":{"date-parts":[[2016,8,16]],"date-time":"2016-08-16T13:45:05Z","timestamp":1471355105000},"page":"e871-e871","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Altered brain arginine metabolism in schizophrenia"],"prefix":"10.1038","volume":"6","author":[{"given":"P","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N D","family":"Collie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D K","family":"Bilkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,16]]},"reference":[{"key":"BFtp2016144_CR1","first-page":"159","volume":"5","author":"BP Blum","year":"2002","unstructured":"Blum BP, Mann JJ . The GABAergic system in schizophrenia. Int J Neuropsychopharmacol 2002; 5: 159\u2013179.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFtp2016144_CR2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2174\/1566524015666150330144821","volume":"15","author":"B Dean","year":"2015","unstructured":"Dean B, Scarr E . Possible involvement of muscarinic receptors in psychiatric disorders: a focus on schizophrenia and mood disorders. Curr Mol Med 2015; 15: 253\u2013264.","journal-title":"Curr Mol Med"},{"key":"BFtp2016144_CR3","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/schbul\/23.3.437","volume":"23","author":"PS Goldman-Rakic","year":"1997","unstructured":"Goldman-Rakic PS, Selemon LD . Functional and anatomical aspects of prefrontal pathology in schizophrenia. Schizophr Bull 1997; 23: 437\u2013458.","journal-title":"Schizophr Bull"},{"key":"BFtp2016144_CR4","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/schbul\/sbp006","volume":"35","author":"OD Howes","year":"2009","unstructured":"Howes OD, Kapur S . The dopamine hypothesis of schizophrenia: version III\u2014the final common pathway. Schizophr Bull 2009; 35: 549\u2013562.","journal-title":"Schizophr Bull"},{"key":"BFtp2016144_CR5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ijdevneu.2010.08.002","volume":"29","author":"DJ Lodge","year":"2011","unstructured":"Lodge DJ, Grace AA . Developmental pathology, dopamine, stress and schizophrenia. Int J Dev Neurosci 2011; 29: 207\u2013213.","journal-title":"Int J Dev Neurosci"},{"key":"BFtp2016144_CR6","first-page":"102","volume":"33","author":"LM Fiori","year":"2008","unstructured":"Fiori LM, Turecki G . Implication of the polyamine system in mental disorders. J Psychiatry Neurosci 2008; 33: 102\u2013110.","journal-title":"J Psychiatry Neurosci"},{"key":"BFtp2016144_CR7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/gbb.12193","volume":"14","author":"F Freudenberg","year":"2015","unstructured":"Freudenberg F, Alttoa A, Reif A . Neuronal nitric oxide synthase (NOS1) and its adaptor, NOS1AP, as a genetic risk factors for psychiatric disorders. Genes Brain Behav 2015; 14: 46\u201363.","journal-title":"Genes Brain Behav"},{"key":"BFtp2016144_CR8","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.jpsychires.2013.04.004","volume":"47","author":"T Uzbay","year":"2013","unstructured":"Uzbay T, Goktalay G, Kayir H, Eker SS, Sarandol A, Oral S et al. Increased plasma agmatine levels in patients with schizophrenia. J Psychiatr Res 2013; 47: 1054\u20131060.","journal-title":"J Psychiatr Res"},{"key":"BFtp2016144_CR9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000070010","volume":"47","author":"M Yanik","year":"2003","unstructured":"Yanik M, Vural H, Kocyigit A, Tutkun H, Zoroglu SS, Herken H et al. Is the arginine-nitric oxide pathway involved in the pathogenesis of schizophrenia? Neuropsychobiology 2003; 47: 61\u201365.","journal-title":"Neuropsychobiology"},{"issue":"Pt 1","key":"BFtp2016144_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3360001","volume":"336","author":"G Wu","year":"1998","unstructured":"Wu G, Morris SM . Arginine metabolism: nitric oxide and beyond. Biochem J 1998; 336 (Pt 1): 1\u201317.","journal-title":"Biochem J"},{"key":"BFtp2016144_CR11","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3233\/JAD-2012-120793","volume":"32","author":"JC de la Torre","year":"2012","unstructured":"de la Torre JC . Cerebral hemodynamics and vascular risk factors: setting the stage for Alzheimer's disease. J Alzheimers Dis 2012; 32: 553\u2013567.","journal-title":"J Alzheimers Dis"},{"key":"BFtp2016144_CR12","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/978-3-540-74805-2_16","volume":"184","author":"R Feil","year":"2008","unstructured":"Feil R, Kleppisch T . NO\/cGMP-dependent modulation of synaptic transmission. Handb Expe Pharmacol 2008; 184: 529\u2013560.","journal-title":"Handb Expe Pharmacol"},{"key":"BFtp2016144_CR13","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","volume":"33","author":"U Forstermann","year":"2012","unstructured":"Forstermann U, Sessa WC . Nitric oxide synthases: regulation and function. Eur Heart J 2012; 33: 829\u2013837, 837a-837d.","journal-title":"Eur Heart J"},{"key":"BFtp2016144_CR14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0031-6997(25)06663-3","volume":"43","author":"S Moncada","year":"1991","unstructured":"Moncada S, Palmer RM, Higgs EA . Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109\u2013142.","journal-title":"Pharmacol Rev"},{"key":"BFtp2016144_CR15","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nrn2214","volume":"8","author":"V Calabrese","year":"2007","unstructured":"Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, Giuffrida Stella AM . Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat Rev Neurosci 2007; 8: 766\u2013775.","journal-title":"Nat Rev Neurosci"},{"key":"BFtp2016144_CR16","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.drudis.2013.05.017","volume":"18","author":"JE Piletz","year":"2013","unstructured":"Piletz JE, Aricioglu F, Cheng JT, Fairbanks CA, Gilad VH, Haenisch B et al. Agmatine: clinical applications after 100 years in translation. Drug Discov Today 2013; 18: 880\u2013893.","journal-title":"Drug Discov Today"},{"key":"BFtp2016144_CR17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0165-6147(00)01460-7","volume":"21","author":"DJ Reis","year":"2000","unstructured":"Reis DJ, Regunathan S . Is agmatine a novel neurotransmitter in brain? Trends Pharmacol Sci 2000; 21: 187\u2013193.","journal-title":"Trends Pharmacol Sci"},{"key":"BFtp2016144_CR18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1196\/annals.1304.004","volume":"1009","author":"J Satriano","year":"2003","unstructured":"Satriano J . Agmatine: at the crossroads of the arginine pathways. Ann N Y Acad Sci 2003; 1009: 34\u201343.","journal-title":"Ann N Y Acad Sci"},{"key":"BFtp2016144_CR19","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/00001756-200403220-00020","volume":"15","author":"H Baba","year":"2004","unstructured":"Baba H, Suzuki T, Arai H, Emson PC . Expression of nNOS and soluble guanylate cyclase in schizophrenic brain. Neuroreport 2004; 15: 677\u2013680.","journal-title":"Neuroreport"},{"key":"BFtp2016144_CR20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1515\/CCLM.2010.014","volume":"48","author":"VV Djordjevic","year":"2010","unstructured":"Djordjevic VV, Stojanovic I, Stankovic-Ferlez D, Ristic T, Lazarevic D, Cosic V et al. Plasma nitrite\/nitrate concentrations in patients with schizophrenia. Clin Chem Lab Med 2010; 48: 89\u201394.","journal-title":"Clin Chem Lab Med"},{"key":"BFtp2016144_CR21","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/oxfordjournals.schbul.a007142","volume":"30","author":"JK Yao","year":"2004","unstructured":"Yao JK, Leonard S, Reddy RD . Increased nitric oxide radicals in postmortem brain from patients with schizophrenia. Schizophr Bull 2004; 30: 923\u2013934.","journal-title":"Schizophr Bull"},{"key":"BFtp2016144_CR22","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/sj.mp.4001779","volume":"11","author":"A Reif","year":"2006","unstructured":"Reif A, Herterich S, Strobel A, Ehlis AC, Saur D, Jacob CP et al. A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function. Mol Psychiatry 2006; 11: 286\u2013300.","journal-title":"Mol Psychiatry"},{"key":"BFtp2016144_CR23","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/sj.mp.4001041","volume":"7","author":"T Shinkai","year":"2002","unstructured":"Shinkai T, Ohmori O, Hori H, Nakamura J . Allelic association of the neuronal nitric oxide synthase (NOS1) gene with schizophrenia. Mol Psychiatry 2002; 7: 560\u2013563.","journal-title":"Mol Psychiatry"},{"key":"BFtp2016144_CR24","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/npp.2014.323","volume":"40","author":"Z Zhang","year":"2015","unstructured":"Zhang Z, Chen X, Yu P, Zhang Q, Sun X, Gu H et al. Evidence for the contribution of NOS1 gene polymorphism (rs3782206) to prefrontal function in schizophrenia patients and healthy controls. Neuropsychopharmacology 2015; 40: 1383\u20131394.","journal-title":"Neuropsychopharmacology"},{"key":"BFtp2016144_CR25","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1038\/tp.2012.76","volume":"2","author":"Y He","year":"2012","unstructured":"He Y, Yu Z, Giegling I, Xie L, Hartmann AM, Prehn C et al. Schizophrenia shows a unique metabolomics signature in plasma. Transl Psychiatry 2012; 2: e149.","journal-title":"Transl Psychiatry"},{"key":"BFtp2016144_CR26","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1523\/JNEUROSCI.22-07-02718.2002","volume":"22","author":"FA Middleton","year":"2002","unstructured":"Middleton FA, Mirnics K, Pierri JN, Lewis DA, Levitt P . Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci 2002; 22: 2718\u20132729.","journal-title":"J Neurosci"},{"key":"BFtp2016144_CR27","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.cca.2007.02.011","volume":"380","author":"M Tomiya","year":"2007","unstructured":"Tomiya M, Fukushima T, Watanabe H, Fukami G, Fujisaki M, Iyo M et al. Alterations in serum amino acid concentrations in male and female schizophrenic patients. Clin Chim Acta 2007; 380: 186\u2013190.","journal-title":"Clin Chim Acta"},{"key":"BFtp2016144_CR28","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/7854_2010_60","volume":"4","author":"DL Levy","year":"2010","unstructured":"Levy DL, Sereno AB, Gooding DC, O'Driscoll GA . Eye tracking dysfunction in schizophrenia: characterization and pathophysiology. Curr Top Behav Neurosci 2010; 4: 311\u2013347.","journal-title":"Curr Top Behav Neurosci"},{"key":"BFtp2016144_CR29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.schres.2010.03.039","volume":"120","author":"NG Cascella","year":"2010","unstructured":"Cascella NG, Fieldstone SC, Rao VA, Pearlson GD, Sawa A, Schretlen DJ . Gray-matter abnormalities in deficit schizophrenia. Schizophr Res 2010; 120: 63\u201370.","journal-title":"Schizophr Res"},{"key":"BFtp2016144_CR30","doi-asserted-by":"crossref","first-page":"e25805","DOI":"10.1371\/journal.pone.0025805","volume":"6","author":"L Qiu","year":"2011","unstructured":"Qiu L, Tian L, Pan C, Zhu R, Liu Q, Yan J et al. Neuroanatomical circuitry associated with exploratory eye movement in schizophrenia: a voxel-based morphometric study. PLoS One 2011; 6: e25805.","journal-title":"PLoS One"},{"key":"BFtp2016144_CR31","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1037\/neu0000035","volume":"28","author":"Y Wang","year":"2014","unstructured":"Wang Y, Yang TX, Su L, Yan C, Wang Y, Huang J et al. Neural correlates of prospective memory in individuals with schizotypal personality features. Neuropsychology 2014; 28: 373\u2013381.","journal-title":"Neuropsychology"},{"key":"BFtp2016144_CR32","unstructured":"Dean B, Pavey G, Chai S, Mendelsohn FA . The localisation and quantification of molecular changes in the human brain using in situ radioligand binding and autoradiography. The Use of CNS Autopsy Tissue in Psychiatric Research: a Practical Guide 2003; 67\u201383."},{"key":"BFtp2016144_CR33","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0169-328X(94)00219-5","volume":"28","author":"AE Kingsbury","year":"1995","unstructured":"Kingsbury AE, Foster OJ, Nisbet AP, Cairns N, Bray L, Eve DJ et al. Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Brain Res Mol Brain Res 1995; 28: 311\u2013318.","journal-title":"Brain Res Mol Brain Res"},{"key":"BFtp2016144_CR34","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1176\/ajp.153.4.533","volume":"153","author":"C Hill","year":"1996","unstructured":"Hill C, Keks N, Roberts S, Opeskin K, Dean B, MacKinnon A et al. Problem of diagnosis in postmortem brain studies of schizophrenia. Am J Psychiatry 1996; 153: 533\u2013537.","journal-title":"Am J Psychiatry"},{"key":"BFtp2016144_CR35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3109\/00048679809062709","volume":"32","author":"SB Roberts","year":"1998","unstructured":"Roberts SB, Hill CA, Dean B, Keks NA, Opeskin K, Copolov DL . Confirmation of the diagnosis of schizophrenia after death using DSM-IV: a Victorian experience. Aust N Z J Psychiatry 1998; 32: 73\u201376.","journal-title":"Aust N Z J Psychiatry"},{"key":"BFtp2016144_CR36","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM . A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248\u2013254.","journal-title":"Anal Biochem"},{"key":"BFtp2016144_CR37","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.schres.2013.06.001","volume":"148","author":"Y Jing","year":"2013","unstructured":"Jing Y, Zhang H, Wolff AR, Bilkey DK, Liu P . Altered arginine metabolism in the hippocampus and prefrontal cortex of maternal immune activation rat offspring. Schizophr Res 2013; 148: 151\u2013156.","journal-title":"Schizophr Res"},{"key":"BFtp2016144_CR38","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neuropharm.2014.02.004","volume":"81","author":"LT Knox","year":"2014","unstructured":"Knox LT, Jing Y, Collie ND, Zhang H, Liu P . Effects of acute phencyclidine administration on arginine metabolism in the hippocampus and prefrontal cortex in rats. Neuropharmacology 2014; 81: 195\u2013205.","journal-title":"Neuropharmacology"},{"key":"BFtp2016144_CR39","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.neurobiolaging.2014.03.013","volume":"35","author":"P Liu","year":"2014","unstructured":"Liu P, Fleete MS, Jing Y, Collie ND, Curtis MA, Waldvogel HJ et al. Altered arginine metabolism in Alzheimer's disease brains. Neurobiol Aging 2014; 35: 1992\u20132003.","journal-title":"Neurobiol Aging"},{"key":"BFtp2016144_CR40","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1073\/pnas.87.2.682","volume":"87","author":"DS Bredt","year":"1990","unstructured":"Bredt DS, Snyder SH . Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 1990; 87: 682\u2013685.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFtp2016144_CR41","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuroscience.2012.09.013","volume":"226","author":"N Gupta","year":"2012","unstructured":"Gupta N, Jing Y, Collie ND, Zhang H, Liu P . Ageing alters behavioural function and brain arginine metabolism in male Sprague-Dawley rats. Neuroscience 2012; 226: 178\u2013196.","journal-title":"Neuroscience"},{"key":"BFtp2016144_CR42","volume-title":"Biostatistics: Experimental Design and Statistical Inference","author":"JF Zolman","year":"1993","unstructured":"Zolman JF . Biostatistics: Experimental Design and Statistical Inference. Oxford University Press: Oxford, UK, 1993."},{"key":"BFtp2016144_CR43","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1177\/0004867415601728","volume":"50","author":"X Ma","year":"2015","unstructured":"Ma X, Wang D, Zhou Y, Zhuo C, Qin W, Zhu J et al. Sex-dependent alterations in resting-state cerebral blood flow, amplitude of low-frequency fluctuations and their coupling relationship in schizophrenia. Aust N Z J Psychiatry 2015; 50: 334\u2013344.","journal-title":"Aust N Z J Psychiatry"},{"key":"BFtp2016144_CR44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00406-015-0607-z","volume":"266","author":"R Wake","year":"2016","unstructured":"Wake R, Miyaoka T, Araki T, Kawakami K, Furuya M, Limoa E et al. Regional cerebral blood flow in late-onset schizophrenia: a SPECT study using 99mTc-ECD. Eur Arch Psychiatry Clin Neurosci 2016; 266: 3\u201312.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"BFtp2016144_CR45","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jpsychires.2015.03.002","volume":"63","author":"J Zhu","year":"2015","unstructured":"Zhu J, Zhuo C, Qin W, Xu Y, Xu L, Liu X et al. Altered resting-state cerebral blood flow and its connectivity in schizophrenia. J Psychiatr Res 2015; 63: 28\u201335.","journal-title":"J Psychiatr Res"},{"key":"BFtp2016144_CR46","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0278-5846(89)90008-0","volume":"13","author":"FZ Kutay","year":"1989","unstructured":"Kutay FZ, Pogun S, Hariri NI, Peker G, Erlacin S . Free amino acid level determinations in normal and schizophrenic brain. Prog Neuropsychopharmacol Biol Psychiatry 1989; 13: 119\u2013126.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFtp2016144_CR47","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jpsychires.2009.02.005","volume":"43","author":"M Thompson","year":"2009","unstructured":"Thompson M, Weickert CS, Wyatt E, Webster MJ . Decreased glutamic acid decarboxylase(67) mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders. J Psychiatr Res 2009; 43: 970\u2013977.","journal-title":"J Psychiatr Res"},{"key":"BFtp2016144_CR48","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1001\/archpsyc.1995.03950220039008","volume":"52","author":"G Tsai","year":"1995","unstructured":"Tsai G, Passani LA, Slusher BS, Carter R, Baer L, Kleinman JE et al. Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch Gen Psychiatry 1995; 52: 829\u2013836.","journal-title":"Arch Gen Psychiatry"},{"key":"BFtp2016144_CR49","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0165-1781(87)90108-9","volume":"22","author":"ER Korpi","year":"1987","unstructured":"Korpi ER, Kleinman JE, Goodman SI, Wyatt RJ . Neurotransmitter amino acids in post-mortem brains of chronic schizophrenic patients. Psychiatry Res 1987; 22: 291\u2013301.","journal-title":"Psychiatry Res"},{"key":"BFtp2016144_CR50","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0006-3223(94)00256-3","volume":"38","author":"GM Gilad","year":"1995","unstructured":"Gilad GM, Gilad VH, Casanova MF, Casero RA Jr . Polyamines and their metabolizing enzymes in human frontal cortex and hippocampus: preliminary measurements in affective disorders. Biol Psychiatry 1995; 38: 227\u2013234.","journal-title":"Biol Psychiatry"},{"key":"BFtp2016144_CR51","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/syn.20828","volume":"65","author":"B Leitch","year":"2011","unstructured":"Leitch B, Shevtsova O, Reusch K, Bergin DH, Liu P . Spatial learning-induced increase in agmatine levels at hippocampal CA1 synapses. Synapse 2011; 65: 146\u2013153.","journal-title":"Synapse"},{"key":"BFtp2016144_CR52","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/hipo.20482","volume":"18","author":"P Liu","year":"2008","unstructured":"Liu P, Collie ND, Chary S, Jing Y, Zhang H . Spatial learning results in elevated agmatine levels in the rat brain. Hippocampus 2008; 18: 1094\u20131098.","journal-title":"Hippocampus"},{"key":"BFtp2016144_CR53","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.neuroscience.2008.06.033","volume":"155","author":"P Liu","year":"2008","unstructured":"Liu P, Gupta N, Jing Y, Zhang H . Age-related changes in polyamines in memory-associated brain structures in rats. Neuroscience 2008; 155: 789\u2013796.","journal-title":"Neuroscience"},{"key":"BFtp2016144_CR54","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/hipo.20561","volume":"19","author":"P Liu","year":"2009","unstructured":"Liu P, Jing Y, Collie ND, Chary S, Zhang H . Memory-related changes in L-citrulline and agmatine in the rat brain. Hippocampus 2009; 19: 597\u2013602.","journal-title":"Hippocampus"},{"key":"BFtp2016144_CR55","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.neuropharm.2012.10.007","volume":"65","author":"M Rushaidhi","year":"2013","unstructured":"Rushaidhi M, Jing Y, Zhang H, Liu P . Participation of hippocampal agmatine in spatial learning: an in vivo microdialysis study. Neuropharmacology 2013; 65: 200\u2013205.","journal-title":"Neuropharmacology"},{"key":"BFtp2016144_CR56","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neuroscience.2015.11.002","volume":"312","author":"Y Jing","year":"2016","unstructured":"Jing Y, Liu P, Leitch B . Region-specific changes in presynaptic agmatine and glutamate levels in the aged rat brain. Neuroscience 2016; 312: 10\u201318.","journal-title":"Neuroscience"},{"key":"BFtp2016144_CR57","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0304-3940(98)00466-2","volume":"250","author":"DJ Reis","year":"1998","unstructured":"Reis DJ, Yang XC, Milner TA . Agmatine containing axon terminals in rat hippocampus form synapses on pyramidal cells. Neurosci Lett 1998; 250: 185\u2013188.","journal-title":"Neurosci Lett"},{"key":"BFtp2016144_CR58","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.neuroscience.2011.07.007","volume":"192","author":"S Seo","year":"2011","unstructured":"Seo S, Liu P, Leitch B . Spatial learning-induced accumulation of agmatine and glutamate at hippocampal CA1 synaptic terminals. Neuroscience 2011; 192: 28\u201336.","journal-title":"Neuroscience"},{"key":"BFtp2016144_CR59","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0022-3565(24)37988-1","volume":"288","author":"XC Yang","year":"1999","unstructured":"Yang XC, Reis DJ . Agmatine selectively blocks the N-methyl-D-aspartate subclass of glutamate receptor channels in rat hippocampal neurons. J Pharmacol Exp Ther 1999; 288: 544\u2013549.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFtp2016144_CR60","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev.pharmtox.42.082701.160735","volume":"42","author":"G Tsai","year":"2002","unstructured":"Tsai G, Coyle JT . Glutamatergic mechanisms in schizophrenia. Annu Rev Pharmacol Toxicol 2002; 42: 165\u2013179.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"BFtp2016144_CR61","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1177\/0269881109102533","volume":"24","author":"T Uzbay","year":"2010","unstructured":"Uzbay T, Kayir H, Goktalay G, Yildirim M . Agmatine disrupts prepulse inhibition of acoustic startle reflex in rats. J Psychopharmacol 2010; 24: 923\u2013929.","journal-title":"J Psychopharmacol"},{"key":"BFtp2016144_CR62","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/7854_2010_61","volume":"4","author":"DL Braff","year":"2010","unstructured":"Braff DL . Prepulse inhibition of the startle reflex: a window on the brain in schizophrenia. Curr Top Behav Neurosci 2010; 4: 349\u2013371.","journal-title":"Curr Top Behav Neurosci"},{"key":"BFtp2016144_CR63","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1126\/science.7906055","volume":"263","author":"G Li","year":"1994","unstructured":"Li G, Regunathan S, Barrow CJ, Eshraghi J, Cooper R, Reis DJ . Agmatine: an endogenous clonidine-displacing substance in the brain. Science 1994; 263: 966\u2013969.","journal-title":"Science"},{"key":"BFtp2016144_CR64","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuropharm.2011.07.012","volume":"62","author":"HG Bernstein","year":"2012","unstructured":"Bernstein HG, Stich C, Jager K, Dobrowolny H, Wick M, Steiner J et al. Agmatinase, an inactivator of the putative endogenous antidepressant agmatine, is strongly upregulated in hippocampal interneurons of subjects with mood disorders. Neuropharmacology 2012; 62: 237\u2013246.","journal-title":"Neuropharmacology"},{"key":"BFtp2016144_CR65","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.neubiorev.2011.08.006","volume":"36","author":"TI Uzbay","year":"2012","unstructured":"Uzbay TI . The pharmacological importance of agmatine in the brain. Neurosci Biobehav Rev 2012; 36: 502\u2013519.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFtp2016144_CR66","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.2174\/092986712803530601","volume":"19","author":"T Uzbay","year":"2012","unstructured":"Uzbay T . A new target for diagnosis and treatment of CNS disorders: agmatinergic system. Curr Med Chem 2012; 19: 5116\u20135121.","journal-title":"Curr Med Chem"},{"key":"BFtp2016144_CR67","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00414-013-0835-6","volume":"128","author":"A Costanza","year":"2014","unstructured":"Costanza A, D'Orta I, Perroud N, Burkhardt S, Malafosse A, Mangin P et al. Neurobiology of suicide: do biomarkers exist? Int J Legal Med 2014; 128: 73\u201382.","journal-title":"Int J Legal Med"},{"key":"BFtp2016144_CR68","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.pneurobio.2009.09.001","volume":"89","author":"C Ernst","year":"2009","unstructured":"Ernst C, Mechawar N, Turecki G . Suicide neurobiology. Prog Neurobiol 2009; 89: 315\u2013333.","journal-title":"Prog Neurobiol"},{"key":"BFtp2016144_CR69","doi-asserted-by":"crossref","first-page":"980","DOI":"10.2174\/18715273113129990095","volume":"12","author":"JA Gross","year":"2013","unstructured":"Gross JA, Turecki G . Suicide and the polyamine system. CNS Neurol Disord Drug Targets 2013; 12: 980\u2013988.","journal-title":"CNS Neurol Disord Drug Targets"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/tp2016144.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tp2016144","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tp2016144.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T18:31:28Z","timestamp":1749061888000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tp2016144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,16]]},"references-count":69,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2016,8]]}},"alternative-id":["BFtp2016144"],"URL":"https:\/\/doi.org\/10.1038\/tp.2016.144","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,16]]},"assertion":[{"value":"13 April 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}